Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.3%, driven by a pullback from Syngene International of 4.0%. On the other hand Tarsons Products is actually up 5.7%. In the past year, the industry has gained 8.7%. Looking forward, earnings are forecast to grow by 22% annually.
Has the Indian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 27 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 25.4x | 71x | 9x |
Fri, 25 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 27.6x | 70.2x | 8.9x |
Sun, 23 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 30x | 59.9x | 8.8x |
Tue, 20 Jun 2023 | ₹1.3t | ₹157.2b | ₹23.0b | 28.1x | 57.8x | 8.5x |
Thu, 18 May 2023 | ₹1.2t | ₹163.0b | ₹28.6b | 33.3x | 42.7x | 7.5x |
Sat, 15 Apr 2023 | ₹1.2t | ₹159.5b | ₹28.4b | 34.7x | 41.3x | 7.3x |
Mon, 13 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 30.9x | 37.1x | 6.6x |
Wed, 08 Feb 2023 | ₹1.0t | ₹158.6b | ₹28.4b | 30.5x | 36.2x | 6.5x |
Fri, 06 Jan 2023 | ₹1.2t | ₹164.9b | ₹34.5b | 30.7x | 35.9x | 7.5x |
Sun, 04 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30x | 35.6x | 7.4x |
Tue, 01 Nov 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 37x | 35.9x | 7.9x |
Thu, 29 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 36.6x | 36x | 7.9x |
Sat, 27 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 37.2x | 35.8x | 7.9x |
Mon, 25 Jul 2022 | ₹1.3t | ₹158.8b | ₹34.2b | 34x | 38.9x | 8.4x |
Wed, 22 Jun 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 32.3x | 36.8x | 7.9x |
Fri, 20 May 2022 | ₹1.4t | ₹149.8b | ₹30.2b | 34.5x | 46.8x | 9.4x |
Sun, 17 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 38.2x | 52.8x | 10.5x |
Tue, 15 Mar 2022 | ₹1.5t | ₹148.3b | ₹29.4b | 34.6x | 51x | 10.1x |
Thu, 10 Feb 2022 | ₹1.5t | ₹139.8b | ₹25.1b | 36.1x | 59.5x | 10.7x |
Sat, 08 Jan 2022 | ₹1.6t | ₹137.8b | ₹24.6b | 32.6x | 63.6x | 11.3x |
Mon, 06 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 31.6x | 65.7x | 11.7x |
Wed, 03 Nov 2021 | ₹1.7t | ₹132.3b | ₹22.7b | n/a | 74.3x | 12.7x |
Fri, 01 Oct 2021 | ₹1.6t | ₹131.1b | ₹22.9b | 22.9x | 69.3x | 12.1x |
Sun, 29 Aug 2021 | ₹1.6t | ₹131.4b | ₹22.9b | 22.1x | 70.7x | 12.3x |
Mon, 05 Jul 2021 | ₹1.5t | ₹127.1b | ₹22.6b | 36.9x | 65.2x | 11.6x |
Thu, 08 Apr 2021 | ₹1.2t | ₹121.4b | ₹21.5b | 32.5x | 56.9x | 10.1x |
Sun, 10 Jan 2021 | ₹1.3t | ₹116.0b | ₹22.4b | 40x | 58.6x | 11.3x |
Sat, 03 Oct 2020 | ₹1.1t | ₹114.7b | ₹22.2b | 27.1x | 48.1x | 9.3x |
48.1x
How does Indian Clinical Research and Equipment compare with similar industries?
IN Market | -1.54% | |
Healthcare | -2.49% | |
Life Sciences | -1.29% | |
Clinical Research and Equipment | -1.29% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TARSONS Tarsons Products | ₹561.35 | 6.6% +₹2.1b | -29.9% | PE43.1x | |
DCAL Dishman Carbogen Amcis | ₹165.15 | 6.5% +₹1.6b | 76.4% | PS1x | |
524394 Vimta Labs | ₹553.35 | 3.3% +₹395.4m | 71.1% | PE25.4x | |
511509 Vivo Bio Tech | ₹35.64 | 1.5% +₹7.7m | -0.3% | PE21.5x |